Novel drug designing approach for dual inhibitors as anti-inflammatory agents: Implication of pyridine template

Biochemical and Biophysical Research Communications

Volumn 301, Issue 1, 2003, Pages 183-186

  Pillai, Ajay D ^a   Rathod, Parendu D ^a   X, Franklin P ^a   Patel, Manoj ^a   Nivsarkar, Manish ^a   Vasu, Kamala K ^a   Padh, Harish ^a   Sudarsanam, Vasudevan ^a  

^a B V PATEL PHARMACEUTICAL EDUCATION AND RESEARCH DEVELOPMENT PERD CENTRE   (India)

Author keywords

Carrageenin; Chronic model; Thiophene

Indexed keywords

ANTIINFLAMMATORY AGENT; AP 29; AP 37; AP 82; AP 84; DEXAMETHASONE; IBUPROFEN; ROFECOXIB; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; EDEMA; EXPERIMENTAL MODEL; INFLAMMATION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTECTION; RAT; STRUCTURE ACTIVITY RELATION; TREATMENT OUTCOME;

EID: 0037474535     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02996-0     Document Type: Article

References (21)

1. Vane J.R. Nature. 231:1971;232-235.
2. Hawkey C.J. The Lancet. 353:1999;307-314.
3. Garret A., Fitzgerald M.D., Carlo Patrono M.D. N. Eng. J. Med. 345:2001;433-442.
4. Zavioco G.B. Drug Market Dev. 10:1999;337-345.
5. Talley J.J., Bertenshaw S.R., Brown D.L., Carter J.F., Graneto M.J., Kellogg M.S., Koboldt C.M., Yuan J., Zhang Y.Y., Seibert K. J. Med. Chem. 43:2000;1661-1663.
6. THE MERCK INDEX, 12th ed., Merck Research Laboratories Division of Merck & Co., Inc., 1996, p. 6977.
7. J.E. Hodgkins, W.P. Reeves, J. Chem. 29 (1964) 3098-3099.
8. W.A. Gregory, US Patent 2,763,692; CA-vol. 51-4429d, 1957.
9. A.D. Pillai, P.D. Rathod, P.X. Franklin, H. Padh, K.V. Kamala, V. Sudarsanam, Indian J. Chem. (2002) (communicated).
10. S. Rajappa, B.J. Advani, Indian J. Chem. 9 (1971) 759-760.
11. Rolfs A., Liebscher J. Org. Syn. 74:1973;257-263.
12. Brown E.V. Synthesis. 1975;358-375.
13. Winter C.A., Risley E.A., Nuss G.W. Proc. Soc. Exp. Biol. Med. 111:1962;544-547.
14. Greenwald R.A. Methods Find. Clin. Pharmacol. 13:1991;75-83.
15. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., Hole K. Pain. 51:1992;5-17.
16. Seibert K., Zhang Y., Leahy Y.K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Proc. Natl. Acad. Sci. USA. 91:1994;12013.
17. Sano H., Hla T., Maier J.A.M., Crofford L.J., Case J.P., Naciag T., Wilder R.L. J. Clin. Invest. 89:1992;97.
18. Anderson G.D., Hauser S.D., McGarity K.L., Bremer M.E., Isakson P.C., Gregory S.A. J. Clin. Invest. 97:1996;2672.
19. Husnkaar S., Hole K. Pain. 30:1987;103-119.
20. B.P. Schimmer, K.L. Parker, in: J.G. Hardman, L.E. Limbird (Eds.), Alfred Goodman Gilman (Consulting Ed.), The Pharmacological Basis of Therapeutics, 10th ed., McGraw-Hill Medical Publishing Division, 2001, pp. 1649-1677.
21. Urquhart E.A. Agents Actions. 32:1991;263.